Senior Medical Director, Lead Endocrinology Global Medical Affairs at Merck Group Darmstadt, Germany
She has experience in pharmaceutical industry starting from 1996 and worked for Eli Lilly for 12 years at the affiliate level in Russia (1996-2001) and Japan ( 2001-2005) as Clinical Research Physician Endocrinology, later as Senior Clinical Research Physician/ Medical Advisor Humatrope (somatropin) Humatrope Product Team Japan, and 2,5 years as medical Advisor/ Global Product Safety Physician responsible for Endocrine Products (Insulins, Insulin Analogs, Somatropin). She spend 4,5 yrs in Japan being involved in submission for adult growth hormone indication and supportring Japan Humatrope product team for ongoing clinical studies (somatropin injectable), R&D for somatropin inhaled formulations and GLP1 analogue phase 2. Speaks basic Japanese (Level 3 Japanese Proficiency). Since May 2008 She has started to work in the area of new developing oncology products for Astrazeneca R&D as Global Patient Safety Physician. She is holding this position up to date.
Specialties: Research and development biotechnology (proteins)endocrinology and metabolism, medical marketing support, Japan clinical development, patient safety, endocrinology, somatropin, diabetes, obesity, IGF, IGFBP3, development of prediction models in clinical studies, validation of quality of life questionnaires, regulatory queries (FDA, EMEA, MHLW), oncology, small molecules, early and late development, pharmacovigilance.